November 27, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Subscribe to Weekly Broadcasts


Study Overview Webinar

December 5, 2023

12-1pm EST

Register Today!

The NRG Oncology 2024 Winter Meeting is Open for Registration!

The Meeting will be held in-person only in Orlando from Thursday, February 15, 2024 - Saturday, February 17, 2024 with select virtual session offerings. Please visit our meeting webpage for the agenda and more information. Register here



NRG-LU006: Study Closure and Termination Memorandum, dated November 20, 2023 (posted on CTSU)



NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More



Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More



NRG-BR008/HERO: Study overview webinars are being held via Microsoft Teams on November 28th at 3pm ET and November 29th at 11am ET. Please see the memorandum, dated October 26, 2023, (posted on CTSU) for details and how to register for one of the sessions. Please note: Google Chrome is the preferred browser to register for the webinars. 



NRG-CC008/SOROCk: There are 4 slots remaining for the 35- <42 age block of the BSO arm. Once these slots are filled accrual will be temporarily held to allow the 35- <42 age block of the BLS arm to enroll the same number of patients. This age blocking is specified in the protocol to ensure equal distributions of patients because this is a non-randomized study. Please see protocol Section 14.5 for a description of the age blocking. 

The BSO arm, for the 35- <42 age block, will re-open once 45 more BLS arm patients are enrolled to that cohort.

NRG-CC010: the study is now open to NRG sites in Japan and South Korea.


GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.


GOG-0225 and GOG-0278: In preparation for final analysis, sites are asked to address all outstanding queries by November 30, 2023 so data analysis can commence. Data queries for GOG-0278 were sent in Medidata Rave and can be responded to in Rave. Queries for GOG-0225 were sent in SEDES and must be replied to in SEDES. If site personnel need access to SEDES for this study, please contact [email protected]. SEDES can be accessed via the GOG Web Menu. The queries issued are imperative to analysis. Your help at this busy time of year is much appreciated! Please contact Linda Gedeon at [email protected] with any questions regarding data entry.

NRG-GY018: ALL queries prefaced with [CDC] must be resolved as soon as possible. This is very time sensitive as resolution of these queries is expected by the end of November. Please resolve all open queries as soon as possible as well as they relate to ongoing data activities. Please refer to the memorandum, dated November 17, 2023 (posted on CTSU) for additional information.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.




Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.



The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday December 13, 2023.











RTOG 1308






NRG-CC011 Study Overview Webinar – Register Today!

NRG Oncology is hosting a webinar for a developing trial, NRG-CC011: Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial. This session will be held on December 5, 2023, 12 – 1pmEST, and led by the study chairs, Dr. Diane Von Ah, Dr. Patricia Ganz and Dr. Brenna McDonald. This trial is designed to examine whether computerized training will improve cancer-related cognitive impairment, including the ability to concentrate, learn new things, remember, and make decisions that affect daily life in breast cancer survivors. Activation is anticipated late 2023/early 2024. 

Click here to register in advance for this meeting

After registering, you will receive a confirmation email containing information about joining the meeting.

NRG Oncology is pleased to report the following abstracts accepted as posters and oral presentations at the American Society of Clinical Oncology (ASCO) GI 2024 symposium this coming January.


Blakeslee SB, Gunn CM, Parker PA, Fagerlin A, Battaglia T, Bevers TB, Bandos H, McCaskill-Stevens W, Kennedy JW, Holmberg C. Talking numbers: how women and providers use risk scores during and after risk counseling - a qualitative investigation from the NRG Oncology/NSABP DMP-1 study. BMJ Open. 2023 Nov 19;13(11):e073138. doi: 10.1136/bmjopen-2023-073138. PMID: 37984961. Read More.

Please note the following upcoming meeting and abstract submission deadline dates



American Association for Thoracic Surgery (AATS); Apr 27-30, 2024; Toronto, ON

American Head & Neck Society (AHNS); May 15-16, 2024; Chicago, IL

American Radium Society (ARS); May 2-5, 2024; Palm Springs, CA

American Society of Breast Surgeons (ABS); Apr 10-14, 2024; Orlando, FL

American Society of Clinical Oncology (ASCO) GI; Jan 18-20, 2024; San Francisco, CA

American Society of Clinical Oncology (ASCO) GU; Jan 25-27, 2024; San Francisco, CA

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-4, 2024; Baltimore, MD

Radiological Society of North America (RSNA); Nov 26-30, 2023; Chicago, IL

San Antonio Breast Cancer Symposium (SABCS); Dec 5-9, 2023; San Antonio, TX

Society of Gynecologic Oncology (SGO); Mar 16-18, 2024; San Diego, CA

Society of Surgical Oncology (SSO) - Advanced Cancer Therapies (ACT); Feb 16-19, 2024; San Juan, Puerto Rico

Society for Urologic Oncology (SUO); Nov 28-Dec 1, 2023; Washington, DC


American Association for Cancer Research (AACR); Apr 5-10, 2024; San Diego, CA; LBA Jan 8, 2024, 11:59 pm ET

American College of Radiology (ACR); Apr 13-17, 2024; Washington, DC; due to publications committee Jan 2, 2024; submission deadline Jan 15, 2024

European Society of Gynaecological Oncology (ESGO); Mar 7-10, 2024; Barcelona, Spain; LBA Jan 15, 2024

ESMO Breast Cancer; May 15-17, 2024; Munich, Germany; due to publications committee; submission deadline Feb 13, 2024, 21:00 CET; LBA Apr 17, 2024, 21:00 CET (placeholder required)

European Society for Radiotherapy and Oncology (ESTRO); May 3-7, 2024; Glasgow, Scotland; LBA Jan 24, 2024

Oncology Nursing Society (ONS); Apr 24-28, 2024; Washington, DC; LBA Jan 11, 2024

Society for Clinical Trials (SCT); May 19-22, 2024; Boston, MA; submission deadline Dec 1, 2023, 11:59 pm ET

Society of Surgical Oncology (SSO); Mar 20-23, 2024; Atlanta, GA; LBA Dec 6, 2023, 11:59 pm ET

Facebook  Twitter  Instagram  LinkedIn